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Background: The importance of measuring the quality of end-of-life care provision is 
undisputed, but determining how best to achieve this is yet to be confirmed. This study 
sought to identify and describe national end-of-life care quality indicators and supporting 
policies used by countries leading in their end-of-life care provision. 
Methods: A systematic environmental scan that included: a web search to identify relevant 
national policies and indicators; hand searching for additional materials; information from 
experts listed for the top ten (n=15) countries ranked in the ‘quality of care’ category of the 
2015 Quality of Death Index study; and snowballing from Index experts.  
Findings: Ten countries (66%) have national policy support for end-of-life care 
measurement, five have national indicator sets, with two indicator sets suitable for all service 
providers. No countries mandate indicator use and there is limited evidence of consumer 
engagement in development of indicators. Two thirds of the 128 identified indicators are 
outcomes measures (62%) and 38% are process measures.  Most indicators pertain to 
symptom management (38%), social care (32%) or care delivery (27%).   
Interpretations: Measurement of end-of-life care quality varies globally and rarely covers all 
care domains or service providers. There is a need to reduce duplication of indicator 
development, involve consumers, consider all care providers and ensure measurable and 







The importance of measuring the quality of end-of-life care is well established and central to 
informing better clinical care, research, policy reform and service commissioning.[1-5] For 
over two decades, measuring the quality of end-of-life care through clinically meaningful 
standards,[5] indicators and data collection tools has been recommended.[6] These terms 
have been used interchangeably but in this article the following definitions apply: ‘standard’ 
is an agreed and preferably evidence-based process that should be undertaken or outcome 
to be achieved for a defined circumstance, symptom, sign or diagnosis;[7] ‘indicator’ is a 
measurable statement ‘with explicit criteria for inclusion, exclusion, time frame and setting’ 
(p79);[7] ‘tool’ is a method and/or instrument used to gather data to inform a quality indicator 
and standard;[7, 8] and ‘measure’ is used only as a verb to avoid ambiguity.  
Progressing measurement of end-of-life care quality would benefit from: collation, analysis 
and adaptation of current indicators for use across different societies and health systems, 
cultures, care settings and diagnoses;[2, 3, 9, 10] development of indicators where gaps 
exist; [2, 3, 11] and decreased variation in indicators to enable greater comparative and 
collaborative opportunities.[3, 9] Given end-of-life care complexity, there is a need for suites 
of indicators that reflect multiple domains of care[1, 2, 5] as well as measuring structures, 
process and outcomes to elucidate the relationship between these.[10, 11]  
A recent international review of quality indicators for end-of-life care was published in 2013 
and concluded that the large number of indicators developed over the preceding years had 
been subject to limitations in quality and capacity for clinical implementation.[10] We went 
beyond this work by examining supporting policies.[10] Better understanding how countries 
are undertaking national quality measurement of end-of-life care to drive improvements and 






To identify and describe national quality indicators and supporting policies used by countries 
leading in their provision of quality end-of-life care. 
Method:  
Design: A systematic environmental scan, undertaken from November 2016 – February 
2017. 
Eligibility criteria 
Data pertaining to a country listed in the top ten countries (n=15) ranked in the ‘quality of 
care’ category within the 2015 Quality of Death Index study[12] were eligible for inclusion. 
This design allowed analysis of methods used to support system-wide end-of-life care 
improvements and the identification of indicators used by both specialist and/or primary care 
providers. This article defines end-of-life care as care provided to a person living with, and 
impaired by, a progressive and eventually fatal condition;[13] specialist palliative care as 
care provided by clinicians whose substantive role is within palliative care;[14] and primary 
care providers as any clinician providing care to those with end-of-life care needs, where 
their substantive work is not within specialist palliative care. This includes, but is not limited 
to, general practitioners, community nurses, staff of aged care facilities and acute care 
hospitals as well as specialist staff (eg. oncologists, geriatricians, renal, cardiac or 
respiratory physicians).[14] 
Data sources  
A systematic web search with predefined search terms and review of the first 10 webpages 
for each search, was undertaken. This search was designed to identify peer reviewed 
publications, non-peer reviewed reports, policies, standards and/or resources relevant to 
measuring quality of end-of-life care. Once this was completed, additional details from the 
countries ranked in the top 10 of the ‘quality of care’ domain of The 2015 Quality of Death 
Index: Ranking palliative care across the world[12] (‘Index’) were sought via: i) A systematic 




handsearching of retrieved documents to identify additional sources for review; and ii) Listed 
key informants (‘experts’) named in the Index[12] who were emailed a set of standard 
questions about the availability and implementation of quality indicators in their country.  
Experts identified in the ‘Index’[12] were asked to address the following three questions: 
1. Does your country have any quality indicators to measure end-of-life care?  
2. Does your country have specific policy guidance in relation to measuring quality of 
end-of-life care?  
3. Is there another key informant who works within this area who I should contact?  
Follow-up emails were sent on two occasions, as needed. Snowballing was utilised if the 
initial experts suggested additional informants. Validation was assured by a review of 
country specific summaries by each relevant expert (Appendix 1).  
Search  
Seven systematic Google searches were completed using the following search terms: dying 
and acute care and/or hospital; palliative and quality; end-of-life care and quality; dying and 
quality; palliative and measures; end-of-life and measures; dying and measures. Within each 
website retrieved, a secondary search for all relevant references was completed, through 
accessing all appropriate hyperlinks (published documents and / or additional web content).  
Ethics approval 
Ethics approval was obtained from a University (HREC ETH16-0939).  
Data collection and items 
The data collected for each of the 15 eligible countries included: all national policy guidance 
for end-of-life care; and national structural, process and/or outcome indicators used to 
monitor quality of end-of-life care by specialist and/or primary care providers. Data were 
extracted into MS Word templates developed a priori that included: information from the 
Google search (date of search, search terms used, number of results, documents retrieved 
per webpage including URL link); information from key countries contacted (details of expert, 




overview (citation details, abstract and key points of relevance to this study). Duplicate files 
were identified at the file management stage (saving files per country) and where a duplicate 
occurred, these were not saved a second time nor counted within the initial documents 
retrieved or screened (Figure 1). Where a country had updated reports or policies, the most 
recent policy informed indicator data for use (prior indicators were removed from analysis if 
no longer in use). However, where relevant several policies informed analysis of approaches 
used to quality measurement of end-of-life care, given policy reform often continued to build 
on work from prior publications. 
Synthesis 
Concurrent data analysis occurred via a two step process: i) Analysis of supporting policies 
and national approaches to quality measurement of end-of-life care within each participating 
country; ii) Analysis of the nationally available end-of-life care indicators from participating 
countries. Mapping was completed to identify availability of national standards, national 
quality indicators, whether they were designed for specialist palliative care or primary care 
providers and whether they were supported by national policy and/or mandated for use. 
Information provided by Index experts was summarised to provide a country specific 
overview and to describe any identified measurement barriers and enablers. Identified 
indicators were categorised in accordance with the Donabedian model[15] and the US 
National Consensus Project Guidelines[16] (‘US Guidelines’), mapped to the recent 
systematic review of available indicators[10] and summarised via descriptive analysis. The 
Donabedian model[15] enabled collation of indicator types (structure, process or outcome), 
independantly categorised by two researchers (CV & TL). Adopting the approach used by 
two recent systematic reviews[10, 11] all indicators were mapped independently by two 
researchers (CV & TL) to the ‘US Guidelines’ domains.[16] Mapping to those indicators 
reported in the most recent systematic review[10] was then completed (CV) with 10% of this 
work independently coded and checked for accuracy (JP). Lastly, to summarise the content 




disagreement in categorisation, mapping or grouping of indicators was discussed to ensure 
consensus. 
Results:  
Seven Google searches, generated 10 items per webpage across 10 webpages per search, 
resulting in a review of 700 items with 99 items meeting the inclusion criteria, including: 
 28 peer reviewed manuscripts;   
 40 policy / report documents from: United Kingdom - UK (n=15 – includes UK n=11, 
England n=2, Scotland n=2), Australia (n=14), US (n=6), Ireland (n=3), Canada 
(n=1), Global (n=1); and 
 31 webpages – US (n=16), Australia (n=7), UK (n=6), Canada (n=2) – resulting in an 
additional 89 documents downloaded for review.  
Handsearching generated another 68 documents for inclusion. Targeted searches of the 15 
countries participating in this study, led to an additional 49 documents for review, a total of 
274 documents included overall (Refer Figure 1).  
Country experts 
Of the 39 experts identified from the 15 included countries, 18 responded (46% response 
rate) with an additional 46 nominees contacted, with 27 providing additional data (59% 
response rate) (see acknowledgements). Comprehensive responses were obtained for all 15 
countries. Verified summaries for each country are presented in Appendix 1. 
National approaches to quality measurement of end-of-life care across 15 countries 
Two thirds (n=10, 66%) of participating countries have current national policy supporting the 
use of quality indicators to measure end-of-life care (Table 1). These policies vary 
considerably. Policies from New Zealand (NZ) and Singapore focus predominantly on 
specialist palliative care provision. England, Australia, NZ and Singapore have national 
standards for end-of-life care. Sweden, Australia, Belgium, The Netherlands and the US 
each have indicator sets available for national end-of-life care measurement. While the 




indicators are for primary care services and the Dutch and US sets are applicable for use by 
all services. Involvement of consumers in the development of indicators is rarely, if at all, 
described by those countries with indicator sets. 
None of the included countries mandate the implementation of their national quality 
indicators with all relying on policy guidance to spur measurement of the quality of end-of-life 
care. In 8 (53%) of the 15 included countries, policy guidance has not led to indicator 
development.  Australia is the only country with a: national policy supporting measurement of 
quality end-of-life care; national standards for optimal end-of-life care; and a national 
indicator set available for use. However, these 20 indicators do not directly map to all 13 









supporting use of quality 
indicators for end-of-life 
care 
National standards 
available for quality 
end-of-life care 
National end-of-life care 
quality indicators available 
for use by specialist 
palliative care providers 
National end-of-life care 
quality indicators available 
for use by primary care 
providers 
Use of quality indicators for 
end-of-life care mandatory for 
specialist palliative care 
providers  
Use of quality indicators for 
end-of-life care mandatory for 
primary care providers 
1. United Kingdom: 
England 
   * 
 
X X X X 
(Hospital accreditation notes 
EOL care) 
1. United Kingdom: 
Scotland 
  X * X  X (under review) X X 
1. United Kingdom: 
Wales 
  X * X X X X 
1. United Kingdom: 
Northern Ireland 
  X * X X X X 
2. Sweden   X * X   X X 
3. Australia         X X X 
4. New Zealand  (focused on specialist 
palliative care) 
   X X X X 
5. France X X * X X X X 
(Hospital accreditation notes 
EOL care) 
6. Canada   X * X X X X 
7. Belgium X X *   X X X 
8. Netherlands X X *     X X 
8. Singapore 
 
 (focused on specialist 
palliative care) 
 ** X X X X 
(Hospital accreditation notes 
EOL care) 
8. Switzerland   (expired) X * X X X X 
8. Taiwan X X X X X X 
8. United States X X *     X (Some payment incentives 
linked to indicator use) 
X (Some payment incentives 
linked to indicator use) 
Totals 10/15 4/15 4/15 3/15 0/15 0/15 
* National guidelines for quality end-of-life care available; **Singapore’s standards are called ‘guidelines’ but written in a very similar way to standards from Australia and New Zealand and therefore have been classified 





Enablers and barriers to implementing national end-of-life care quality indicators  
Significant work is underway to strengthen the measurement of quality end-of-life care 
provision globally (Appendix 1), with four key enablers for development and implementation 
of national end-of-life quality indicators identified, namely:  
1. National project / program work (Australia, Belgium and The Netherlands); 
2. Use of mandatory accreditation frameworks (England, France, Australia and 
Singapore);  
3. Availability of a national palliative care data registry (Sweden); and 
4. Incentivising quality indicator use (US). 
Three main barriers were identified by experts that prevent quality measurement of end-of-
life care, including: 
1. Lack of a national data collection system focused on quality of end-of-life care 
(England); 
2. Legal and regulatory constraints in relation to data access (England); and 
3. Policy frameworks that focus on availability, access and activity, rather than a more 
holistic understanding of quality end-of-life care (England and France). 
An overview and analysis of nationally available end-of-life care indicators  
There are 128 indicators identified from five countries: The Netherlands (n=43), Belgium 
(n=31), US (n=25), Australia (n=20) and Sweden (n=9) (Appendix 3). The majority (62%, 
n=79) are outcome indicators, with the remaining (38%, n=49) classified as process 
indicators. No structural indicators were identified (Figure 2). 
The majority of indicators, when mapped to the ‘US Guidelines’ domains,[16] refer to 
physical care (n=48, 38%), social care (n=41, 32%) or processes of care delivery (n=35, 
27%).  There are a smaller number of indicators measuring psychological (n=21, 16%), 
spiritual / religious care (n=21, 16%) or the quality of care throughout the dying process 




(n=9, 7%).  Belgium and the Netherlands are the only countries with a set of indicators that 
map to all domains. Physical aspects of care are the major focus for Australia (n=15, 75%) 
and Sweden (n=6, 67%). Cultural aspects of care are never explicitly referred to, with 
indicators mapped to this domain measuring either quality of life, how a patient or family 
member was feeling, degree of preparedness for saying goodbye and perceptions of the 
quality of death.   
Mapping the 128 national indicators (Appendix 3) to the 2013 systematic review of quality 
end-of-life care indicators[10], found: 32 (18%) were listed, considerable overlap in indicator 
availability (e.g., multiple indicators measuring aspects of pain screening, assessment and/or 
management) with ‘similar’ indicators used on 73 occasions. There are 390 distinct quality 
indicators listed across the systematic review[10] and this study. Three of the five 
participating countries with national indicators sets (Australia, The Netherlands and US) 
were within the published review’s indicator set.[10] Appendix 4 provides an overview of this 
mapping work, including visibility of all such indicators.  
The descriptive summation of the 128 national indicators reveals: 36 key measurement 
domains; 13 occasions where a single country is measuring a key area in isolation (e.g. 
nausea measured by Australia and pressure ulcers measured by Sweden); and 23 
occasions where two or more countries are measuring the same key area using different 
indicators. There are 37 indicators measuring symptom management with 15 specifically for 
pain (inclusive of screening, assessment and / or management). There are 9 indicators for 
psychological / spiritual / religious aspects of care and 8 measuring information provision to 
the patient. There are 11 occasions where the indicators measure multiple components of 
care and could not be mapped to one domain. Figure 3 provides an overview of the mapping 
of indicators to key domains, Table 2 notes the mapping in line with each participating 
country and Appendix 3 at each indicator level. All five countries with national indicators for 
measuring the quality of end-of-life care have indicators relating to general symptom 




Table 2: Number and type of indicators available for national use to measure quality of end-of-life care listed by country of origin, 
mapped to the ‘US Guidelines’ domains[16] and key measurement domains 
Indicators available by 
participating country.  
 
Type of Indicator 






Key domains of measurement  
 
 
Australia – 20 indicators for 




Domains 1, 2, 3, 4 and 5 General symptom management; Pain; Fatigue; Dyspnoea; Nausea; Bowel management; Psychological / 
spiritual / religious care for the patient; Family problems; Service access; Resolution of unstable phase.  
Belgium – 31 indicators 
available for specialist palliative 
care providers  
14 Process 
17 Outcome 
Domains 1 – 8  General symptom management; Pain; Dyspnoea; Quality of life measure; Respect for patient autonomy; 
Information provision – patient; Information provision – family;  Family support; Evident MDT care; 
Treatment preference discussion and/or documentation – patients; Treatment preference discussion 
and/or documentation – families; Discussion about care objectives; Family physician contact for patient; 
Quality of death measure; Service access; Acute care use; Indicators covering multiple categories.   
Netherlands – 43 indicators 
available for generalist and 




Domains 1 – 8 General symptom management; Pain; Fatigue; Dyspnoea; Bowel management; Physical care; 
Psychological / spiritual / religious care for the patient; Respectful care; Respect for patient autonomy; 
Preparation for death; Quality of death measure; Location of preference; Integrated / coordinated care 
and care expertise; Information provision – patient; Treatment preference discussion and/or 
documentation – patients; Service access; Family support; Respect for family member’s autonomy; 
Information provision – family; Bereavement; Indicators covering multiple categories. 
Sweden – 9 indicators available 
for generalist providers 
8 Process 
1 Outcome 
Domains 1, 2 and 7 General symptom management; Pain; Oral health; Pressure ulcers; Psychological / spiritual / religious 
care for the patient; Discussion about care objectives; Coverage in a registry of palliative care; Acute 
care use.  
United States – 25 indicators 
available for generalist and 





Domains 1, 2, 3, 4, 5, 7 and 8 General symptom management; Pain; Dyspnoea; Bowel management; Psychological / spiritual / 
religious care for the patient; Respectful care; Treatment preference discussion and/or documentation – 
patients; ICD deactivation; Information provision – family; Family support; Service access; Acute care 
use; Receiving chemotherapy in last 14 days of life; Hospice evaluation; Indicators covering multiple 
categories. 
*Domain headings from the United States Clinical Practice Guidelines for Quality Palliative Care, Third Edition: Domain 1: Structure and Processes of Care; Domain 2: Physical Aspects of 
Care; Domain 3: Psychological and Psychiatric Aspects of Care; Domain 4: Social Aspects of Care; Domain 5: Spiritual, Religious and Existential Aspects of Care; Domain 6: Cultural Aspects of 
Care; Domain 7: Care of the Patient at the End of Life; Domain 8: Ethical and Legal Aspects of Care  





This environmental scan identified wide global variability in progress towards establishing 
national approaches to robust, feasible and sustainable mechanisms for measurement of the 
quality of end-of-life care provision.[18-21] Belgium and the Netherlands currently have the 
most comprehensive indicator sets available at national levels. However, Belgium’s set is 
currently only for specialist palliative care providers and the Netherlands’ indicator set was 
made available as part of a five-year project, due for completion this year.  
Indicators are currently only used by a third of countries identified as leading in end-of-life 
care provision, and none of the countries mandated indicator use. Two of the five indicator 
sets we identified: were designed for use by specialist palliative care services rather than 
more generally measuring end-of-life care provided by primary care providers; and only two 
addressed all of the ‘US Guidelines’ domains.[16] While hospital accreditation requirements 
in England, France and Singapore incorporate aspects of end-of-life care, no national 
indicators have been developed specifically to support this process in acute care. 
Enabling system-wide improvements for end-of-life care provision, requires: the integration 
of indicators into existing healthcare systems; and indicators that are relevant to primary 
care providers and specialist palliative care providers. While, Sweden reports improvements 
in end-of-life care resulting from integration of indicators across all care settings, for all care 
providers, [18] their current indicator set does not: cover all care domains; or consider 
structural, process and outcomes and subsequent causal linkages. No participating 
countries had a comprehensive set of national end-of-life care indicators, relevant to all care 
providers across care settings. The development and implementation of a comprehensive 
set of indicators would support wide-scale improvements in patient and family experiences. 
Given the increasing number of people living with complex illnesses, focusing indicator 
development only on specialist palliative care services alone reinforces the status quo and 




Debate continues as to whether indicators should be mandated or voluntary, with a recent 
US publication proposing that a nationally mandated approach will enable progression in 
measurement of, and improvements within, patient safety.[22] Without a mandated 
approach, our data suggest that implementation is inconsistent and/or reliant upon project 
funding affecting sustainability and usability of data for comparative purposes. However, 
mechanisms to mandate need careful consideration with a specific focus on whether 
incentivising is useful, whether public reporting of data assists performance and whether 
data should be used with a punitive intention.[23] Given the aim for such reporting is to drive 
system-wide improvements, policy makers and standard enforcers are advised to consider 
such approaches in line with best practice for performance management.[23] However, the 
complexity of this work should not be underestimated. Each country has unique data 
collection, data regulation, policy and population requirements to consider. Nevertheless, 
development of national data registries, incentivising indicator use, appropriate utilisation of 
accreditation processes and commencing work through funded national programs have all 
been highlighted as mechanisms for enabling progression in quality measurement of end-of-
life care (Appendix 1). 
Current development and implementation of quality indicators for end-of-life care falls short 
of key recommendations from a recent systematic review.[10] No national indicator sets 
include structural measures with recommendations highlighting the need for structure, 
process and outcome indicators to truly inform a review of quality end-of-life care; and 
advice to adapt indicators across countries to limit development of new indicators and 
enhance opportunities for benchmarking has not been implemented with all countries having 
unique sets of indicators with both duplication and heterogeneity evident. There are 
opportunities to learn from different approaches and indicators used, to share successes and 
challenges in the measurement of optimal end-of-life care and for policy makers, 
researchers and service commissioners to use this information in line with cultural and 




Given the focus on person-centred care and consumer-driven healthcare, it is time that the 
healthcare sector also partnered with consumers to: identify a set of indicators that can 
assist optimal end-of-life care provision across all care settings (acute, community and aged 
care); and implement these nationally so service commissioning is in line with best practice. 
Driving such work from a consumer perspective will ensure that all system level 
improvements are in line with patient and family expectations of what constitutes good end-
of-life care.[24, 25] It is also timely to develop an international repository of available 
indicators to limit ongoing development of ‘similar’ indicators and inform development of 
indicators where these are not available (E.g. cultural care). Such work could lead to 
international consensus on specific indicators that are of shared importance – for example, 
in relation to symptom management. Opportunities for collaboration and learning from other 
countries will flow directly from such an approach. 
Crafting a set of national quality indicators that draws together key information from multiple 
tools in a feasible and sustainable way is complex. For an indicator set to be feasible for 
clinical settings, the number and frequency of measuring is an important consideration. It 
also requires a commitment to: utilise existing data sources[26]; carefully consider tools that 
inform quality indicators and standards,[1-3, 5, 6, 27] prioritise tools that assess consumer-
identified areas of importance;[27] can be implemented into routine clinical practice[1, 28] 
and preference patient reported data.[1, 9, 29] Enabling quality measurement of end-of-life 
care also requires assessing the validity and usefulness of available national data sets[2]  
and better understanding how to use information from proxies when patients are unable to 
self-report.[2] Finally, ensuring a pathway between indicators and improved patient and 
family experience is fundamental to successfully effecting system level improvements.  
Strengths and limitations  
The involvement of key experts from all participating countries is a strength of this study. 
Their contribution has ensured a realistic view of practice within the context of future plans, 




of standardised questions for experts and the systematic approach we used to search for 
and collect data limits the risk of bias. We adhered to standards for reporting a systematic 
review to the degree possible, recognising that such standards do not currently account for 
internet inclusive searches.  
The study’s main limitation is that we restricted participation to the 15 countries ranked in the 
top 10 countries delivering quality end-of-life care according to the ‘Index’.[12] Other 
countries may be working in this area and may have national quality indicators not included 
in our review. Focusing on the countries ranked in the top 10 for quality of care was intended 
to instil at least some confidence in the quality of policies in the absence of research 
evidence. Limiting our inclusion to national indicators rather than those used at local or 
regional levels means we have not identified quality indicators currently used by some 
services. This approach enabled reviewing in line with national policy guidance and reduced 
contextual heterogeneity at least to some extent. Whilst the ‘US Guidelines’[16] had 
previously been used to map indicators to key domains,[10, 11] these were hard to separate 
at times (E.g. significant overlap between domain 1 – structure and processes of care and 
domain 4 – social aspects of care) and this led to us taking an inclusive approach. As a 
result, the mapping may over represent availability of measures in some domains. Finally, 
similar to other reviews, this study has focused purely on quality measurement, without 
inclusion of safety.[3, 5, 10] Despite some progress noted in healthcare safety measurement 
over the past 15 years, considerable work is required to enable this in a systematic way[22] 
for people with end-of-life care needs.[30]  
Conclusion 
Measuring the quality of end-of-life care is a global priority, as it is key to ensuring access to 
high quality care across all settings, regardless of where you live. The collaborative 
development of a consumer-centred set of quality indicators, mapped to available standards 
and data sources, to inform local, regional and national understanding of end-of-life care 




development that supports system-level improvements in end-of-life care provision will need 
to consider both primary care providers as well as specialist palliative care providers and all 
care settings.  A collaborative approach will reduce duplication of effort, facilitate rapid 
transfer of learnings from key successes and provide the foundation for future 
benchmarking.  
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